70 related articles for article (PubMed ID: 20144849)
1. Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms.
Jordan BF; Peeterbroeck J; Karroum O; Diepart C; Magat J; Grégoire V; Gallez B
Cancer Lett; 2010 Jul; 293(2):213-9. PubMed ID: 20144849
[TBL] [Abstract][Full Text] [Related]
2. [A design of a novel compound S-nitrosocaptopril possessing the capacities of both angiotensin converting enzyme inhibitors and NO donors].
Jia L
Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):53-6. PubMed ID: 12532851
[No Abstract] [Full Text] [Related]
3. The effects of S-nitrosocaptopril on canine coronary circulation.
Nakae I; Takahashi M; Kinoshita T; Matsumoto T; Kinoshita M
J Pharmacol Exp Ther; 1995 Jul; 274(1):40-6. PubMed ID: 7616425
[TBL] [Abstract][Full Text] [Related]
4. Insulin increases the sensitivity of tumors to irradiation: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consumption.
Jordan BF; Grégoire V; Demeure RJ; Sonveaux P; Feron O; O'Hara J; Vanhulle VP; Delzenne N; Gallez B
Cancer Res; 2002 Jun; 62(12):3555-61. PubMed ID: 12068004
[TBL] [Abstract][Full Text] [Related]
5. The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
Jia L; Blantz RC
Eur J Pharmacol; 1998 Jul; 354(1):33-41. PubMed ID: 9726628
[TBL] [Abstract][Full Text] [Related]
6. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.
Crokart N; Radermacher K; Jordan BF; Baudelet C; Cron GO; Grégoire V; Beghein N; Bouzin C; Feron O; Gallez B
Cancer Res; 2005 Sep; 65(17):7911-6. PubMed ID: 16140962
[TBL] [Abstract][Full Text] [Related]
7. The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs.
Shaffer JE; Lee F; Thomson S; Han BJ; Cooke JP; Loscalzo J
J Pharmacol Exp Ther; 1991 Feb; 256(2):704-9. PubMed ID: 1899703
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosocaptopril. II. Effects on vascular reactivity.
Cooke JP; Andon N; Loscalzo J
J Pharmacol Exp Ther; 1989 Jun; 249(3):730-4. PubMed ID: 2659777
[TBL] [Abstract][Full Text] [Related]
9. ACE inhibition restores the vasodilator potency of the endothelium-derived relaxing factor, L-S-nitrosocysteine, in conscious Spontaneously Hypertensive rats.
Lewis SJ; Hashmi-Hill MP; Owen JR; Sandock K; Robertson TP; Bates JN
Vascul Pharmacol; 2006 Jun; 44(6):491-507. PubMed ID: 16713366
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of S-nitrosocaptopril on vasomotor tone.
Lin MJ; Yang XP; Wang J; Jia BJ; Jia L
Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):485-8. PubMed ID: 10375817
[TBL] [Abstract][Full Text] [Related]
11. Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
van Wijngaarden J; Smit AJ; de Graeff PA; van Gilst WH; van der Broek SA; van Veldhuisen DJ; Lie KI; Wesseling H
J Cardiovasc Pharmacol; 1994 Feb; 23(2):240-5. PubMed ID: 7511753
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Loscalzo J; Smick D; Andon N; Cooke J
J Pharmacol Exp Ther; 1989 Jun; 249(3):726-9. PubMed ID: 2659776
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin converting enzyme inhibitors on tolerance of nitroglycerin.
Fang Z; Li Y; Liu D; Li Y; Hao F; Liu Z
Chin Med J (Engl); 1995 Dec; 108(12):919-22. PubMed ID: 8728945
[TBL] [Abstract][Full Text] [Related]
14. Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier.
Park JW
Biochem Biophys Res Commun; 1992 Nov; 189(1):206-10. PubMed ID: 1449475
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
Jia L; Wu CC; Guo W; Young X
Eur J Pharmacol; 2000 Mar; 391(1-2):137-44. PubMed ID: 10720645
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm.
Raghavendra V; Chopra K; Kulkarni SK
Neuropeptides; 2001 Feb; 35(1):65-9. PubMed ID: 11346312
[TBL] [Abstract][Full Text] [Related]
17. Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin.
Matsumoto T; Takahashi M; Nakae I; Kinoshita M
J Pharmacol Exp Ther; 1995 Dec; 275(3):1247-53. PubMed ID: 8531088
[TBL] [Abstract][Full Text] [Related]
18. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
Resende AC; Pimentel AM; de Moura RS
Clin Exp Pharmacol Physiol; 2004 Nov; 31(11):756-61. PubMed ID: 15566389
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the renin-angiotensin system in heart failure in conscious dogs.
Murakami M; Suzuki H; Naitoh M; Matsumoto A; Kageyama Y; Tsujimoto G; Saruta T
J Hypertens; 1995 Dec; 13(12 Pt 1):1405-12. PubMed ID: 8866902
[TBL] [Abstract][Full Text] [Related]
20. Protection of the ischemic myocardium by the converting-enzyme inhibitor zofenopril: insight into its mechanism of action.
Ferrari R; Cargnoni A; Curello S; Ceconi C; Boraso A; Visioli O
J Cardiovasc Pharmacol; 1992; 20(5):694-704. PubMed ID: 1280730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
